Adaptin Bio (APTN) Retained Earnings (2022 - 2026)

Adaptin Bio has disclosed Retained Earnings across 5 years of filings, most recently posting -$11.6 million for Q2 2026.

• In Q2 2026, Retained Earnings fell 273.22% year-over-year to -$11.6 million; the TTM figure through Jun 2026 stood at -$11.6 million (down 273.22% YoY), while the FY2025 annual figure was -$9.3 million, down 125.3% from the prior year.
• Retained Earnings came in at -$11.6 million for Q2 2026 at Adaptin Bio, down from -$10.4 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $6.7 million in Q2 2025 to a low of -$11.6 million in Q2 2026.
• Average Retained Earnings over 5 years is -$2.4 million, with a median of -$206167.0 recorded in 2024.
• Year-over-year, Retained Earnings slumped 3536.99% in 2024 and jumped 3894.16% in 2025.
• Over 5 years, Retained Earnings stood at -$27804.0 in 2022, then tumbled by 307.84% to -$113397.0 in 2023, then tumbled by 3536.99% to -$4.1 million in 2024, then tumbled by 125.3% to -$9.3 million in 2025, then slipped by 25.31% to -$11.6 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$11.6 million in Q2 2026, -$10.4 million in Q1 2026, and -$9.3 million in Q4 2025.